Barroso et al. reported that a single nucleotide mutation (P467L or V290M) in the ligand binding domain of PPARγ is present in subjects with diabetes mellitus and hypertension, suggesting that an alteration in this receptor is important in the control of insulin sensitivity and blood pressure and the presence of this mutation predisposes to disease [7]. Here, PPARG is linked to hypertensive disorder.